Cost-Effectiveness Analysis Of Venetoclax For Treatment Of Refractory/Relapsed Chronic Lymphocytic Leukemia With Or Without 17P Deletion In Bulgaria
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2119
https://www.valueinhealthjournal.com/article/S1098-3015(17)32453-1/fulltext
Title :
Cost-Effectiveness Analysis Of Venetoclax For Treatment Of Refractory/Relapsed Chronic Lymphocytic Leukemia With Or Without 17P Deletion In Bulgaria
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32453-1&doi=10.1016/j.jval.2017.08.2119
First page :
A754
Section Title :
Research on Methods Studies
Open access? :
No
Section Order :
1943